Zhou Li, Li Qifu, Wang Jiandong, Huang Canhua, Nice Edouard C
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P. R. China.
Department of Neurology, The Affiliated Hospital of Hainan Medical College, Haikou, Hainan, P. R. China.
Proteomics Clin Appl. 2016 Apr;10(4):516-31. doi: 10.1002/prca.201500081. Epub 2015 Dec 9.
Oncoproteomics is the study of cancer-associated proteins and their interactions using proteomic technologies. It is expected to play a crucial role in the detection and surveillance of cancer, as well as in the development of personalized medicine for oncology. In this review, we will outline the current status, advantages, and limitations of oncoproteomics. Further, we will discuss available strategies arising from a better understanding of oncoproteomics, including integrated omics approaches, to overcome current problems in the discovery and validation of biomarkers, identification of novel drug targets, and management of personalized medicine.
肿瘤蛋白质组学是利用蛋白质组学技术研究癌症相关蛋白质及其相互作用的学科。它有望在癌症的检测和监测以及肿瘤个性化医疗的发展中发挥关键作用。在本综述中,我们将概述肿瘤蛋白质组学的现状、优势和局限性。此外,我们将讨论通过更好地理解肿瘤蛋白质组学而产生的可用策略,包括整合组学方法,以克服生物标志物发现与验证、新药物靶点识别及个性化医疗管理方面的当前问题。